Please login to the form below

Not currently logged in
Email:
Password:

ALK-Abello

This page shows the latest ALK-Abello news and features for those working in and with pharma, biotech and healthcare.

ALK-Abello debuts its birch pollen allergy therapy in Germany

ALK-Abello debuts its birch pollen allergy therapy in Germany

Key market for the new product. Danish drugmaker ALK-Abello has launched its tree pollen immunotherapy Itulazax in Germany, its first market, following its European approval earlier this year. ... Tree pollen allergy is highly prevalent in northern Europe

Latest news

More from news
Approximately 4 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • Deal Watch July 2016 Deal Watch July 2016

    And Finally, Reality Bites. ALK-Abello has issued a press release announcing that Merck &Co has walked away from the deal agreed in 2007 (with Schering-Plough) for the allergy treatments ... No sales figures have been released by either side, but

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • ALK-Abello appoints Søren Jelert as CFO ALK-Abello appoints Søren Jelert as CFO

    He will be based at the company’s headquarters in Denmark. Dansih allergy immunotherapy company ALK-Abello has appointed Søren Jelert as its new chief financial officer, a role that sees ... ALK.”. Jelert will be based at ALK’s headquarters in

  • Cello Health Consulting expands its UK team Cello Health Consulting expands its UK team

    Tarplee has over 30 years of life science industry experience and previously worked for the likes of Adherium, ALK Abello, Sanofi and Abbott.

  • ALK Abelló's John Tarplee joins Adherium ALK Abelló's John Tarplee joins Adherium

    UK. He brings over 30 years of sales and market expansion expertise, most recently in the role of senior vice president at Danish immunotherapy company ALK Abelló where he oversaw its

  • Lars Dreiøe joins Sobi in senior quality and compliance role Lars Dreiøe joins Sobi in senior quality and compliance role

    Moves to the Swedish rare diseases company from Denmark's ALK. Swedish rare diseases company Sobi has appointed Lars Dreiøe as senior vice president chief quality and compliance officer. ... He will join the firm in January from Danish allergy vaccine

  • ALK Abello appoints UK managing director ALK Abello appoints UK managing director

    Sean Connor joins from Shire. ALK Abello has appointed Sean Connor to the role of UK managing director and director of international markets.

More from appointments
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Langland Langland

    Abbott. Corporate. Hidrasec. Influvac. Synagis. Teveten. ALK-Abelló. Jext. Astellas Advagraf. Modigraf.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics